Macular degeneration: open trials in Switzerland

11 open trials have a site in Switzerland. Registry data; only the trial team decides who can take part.

NCT06847542
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Trial Treatment · Phase 3 · Hoffmann-La Roche
Berner Augenklinik, Bern · Pallas Klinik Olten, Olten · Kantonsspital St. Gallen, Sankt Gallen
Registry updated 2026-11-06
NCT06635148
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC
Inselspital Universitätsspital Bern, Bern
Registry updated 2026-11-03
NCT03683251
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Trial Treatment · Phase 3 · Hoffmann-La Roche
Universitatsspital Basel Augenklinik Klinik, Basel · Inselspital Universitaetsklinik fuer Augenheilkunde;Marie-Colinet-Haus, Bern · Vista Klinik Ophthalmologische Klinik, Binningen · Fondation Asile Des Aveugles ? Jules Gonin Eye Hospital, Lausanne · Stadtspital Triemli Ophthalmologische Klinik, Zurich
Registry updated 2026-10-27
NCT07440225
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Trial Treatment · Phase 2/3 · EyeBiotech Ltd.
University Hospital Basel, Eye Clinic, Basel · Swiss Eye Institute and Berner Augenklinik, Bern · Vista Augenklinik Binningen, Binnigen · Fondation Asile des aveugles (Hôpital Ophtalmique Jules-Gonin), Lausanne · Stadtspital Zurich Triemli Forschungszentrum Augenklinik, Zurich
Registry updated 2026-10-02
NCT07606365
A Study in Adults With Geographic Atrophy
Trial Treatment · Phase 2 · Sitala Bio LTD
Ente Ospedaliero Cantonale, Bellinzona · Augenarzte Bern Zentrum Marktgasse, Bern · Berner Augenklinik, Bern · Vista Augenklinik Binningen, Binningen · Swiss Visio Montchoisi, Lausanne · Stadtspital Triemli, Zurich
Registry updated 2026-09-21
NCT04663750
Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).
Trial Treatment · Phase 3 · King's College Hospital NHS Trust
University Hospital Bern, Bern · Jules-Gonin Hospital, Lausanne
Registry updated 2026-09-11
NCT06659445
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Trial Treatment · Phase 2 · ONL Therapeutics
Augenarzt Praxisgemeinschaft Gutblick AG, Bern · Vista Augenklinik Binningen, Binningen · Hospital Ophthalmic Jules-Gonin Foundation, Lausanne · Swiss Visio Retina Research Center, Lausanne · Augenarzt Praxisgemeinschaft Gutblick AG, Zurich · Stadtspital Zurich Triemli, Augenklinik, Forschungszentrum, 2K.14, Zurich
Registry updated 2026-09-10
NCT06990269
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Trial Treatment · Phase 2 · ADARx Pharmaceuticals, Inc.
Basel · Bern · Olten
Registry updated 2026-09-03
NCT07434713
EarLy Treatment Response in nEoVascular Macular Degeneration With Eylea 8mg: ELEV8 A Prospective Observational Open Label Study Investigating the Fluid Dynamics During Early Response to Aflibercept 8mg in Patients With Exudative Age-related Macular Degeneration (AMD).
Research · Insel Gruppe AG, University Hospital Bern
Dept. of Ophthalmology, University Hospital, Inselspital, Bern
Registry updated 2026-02-27
NCT06351657
Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
Research · Medical University of Vienna
Vista Klinik Binningen, Binningen · University of Zurich, Zurich
Registry updated 2025-05-15
NCT06351670
Personalised Monitoring of Early and Intermediate Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
Research · Medical University of Vienna
Vista Klinik Binningen, Binningen · University of Zurich, Zurich
Registry updated 2025-05-15

All Macular degeneration trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error